Hunan Hansen Pharmaceutical Co. Ltd. | Ownership
Companies that own Hunan Hansen Pharmaceutical Co. Ltd.
Shaanxi International Trust Co. Ltd. (Invt Mgmt)
14,777,700
5.15%
14,252,504
1.49%
09/30/2017
Yunnan International Trust Co., Ltd.
14,331,000
5%
14,331,000
1.14%
09/30/2017
China Fortune International Trust Co. Ltd.
6,798,076
2.37%
6,798,076
1.43%
09/30/2017
Everbright Xinglong Trust Co. Ltd.
6,653,027
2.31%
6,653,027
2.85%
09/30/2017
CSC Financial Co., Ltd. (Investment Management)
6,408,035
2.24%
6,408,035
27.62%
09/30/2017
China Investment Corp. (Investment Management)
2,835,600
0.99%
0
0.02%
09/30/2017
China Universal Asset Management Co., Ltd.
572,133
0.2%
-199,600
0.01%
12/31/2017
Lion Fund Management Co., Ltd.
19,500
0.01%
19,500
0%
12/31/2017
Chang Xin Asset Management Co., Ltd.
0
0%
-2,250,020
0%
12/31/2017
GF Fund Management Co., Ltd.
0
0%
-96,600
0%
12/31/2017
| Address |
Longling Industrial Park
Yiyang Hunan 413000
China
|
|
Employees
|
- |
| Website |
http://www.hansenzy.com |
| Updated |
07/08/2019 |
| Hunan Hansen Pharmaceutical Co. Ltd. engages in the research, development, manufacture, and sale of Chinese medicines. Its products include intravenous medicine, capsules, syrups, and pills for cardiovascular, respiratory, and gastrointestinal diseases. The company is headquartered in Hunan, China. |
